These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10634224)

  • 21. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of probiotics in the treatment of inflammatory bowel disease.
    Hart AL; Stagg AJ; Kamm MA
    J Clin Gastroenterol; 2003 Feb; 36(2):111-9. PubMed ID: 12544192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics--role in inflammatory bowel disease.
    Gionchetti P; Amadini C; Rizzello F; Venturi A; Palmonari V; Morselli C; Romagnoli R; Campieri M
    Dig Liver Dis; 2002 Sep; 34 Suppl 2():S58-62. PubMed ID: 12408442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal flora and mucosal immune responses.
    Heller F; Duchmann R
    Int J Med Microbiol; 2003 Apr; 293(1):77-86. PubMed ID: 12755368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics and prebiotics in chronic inflammatory bowel diseases.
    Ewaschuk JB; Dieleman LA
    World J Gastroenterol; 2006 Oct; 12(37):5941-50. PubMed ID: 17009391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.
    Ewaschuk JB; Tejpar QZ; Soo I; Madsen K; Fedorak RN
    Curr Gastroenterol Rep; 2006 Dec; 8(6):486-98. PubMed ID: 17105688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Probiotics in inflammatory bowel disease: controlled trials and perspectives].
    Seksik P; Marteau P
    Therapie; 2004; 59(1):83-7. PubMed ID: 15199674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriotherapy using fecal flora: toying with human motions.
    Borody TJ; Warren EF; Leis SM; Surace R; Ashman O; Siarakas S
    J Clin Gastroenterol; 2004 Jul; 38(6):475-83. PubMed ID: 15220681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics and Their Use in Inflammatory Bowel Disease.
    Amer M; Nadeem M; Nazir SUR; Fakhar M; Abid F; Ain QU; Asif E
    Altern Ther Health Med; 2018 May; 24(3):16-23. PubMed ID: 29135456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manipulation of the bacterial flora in inflammatory bowel disease.
    Marteau P; Seksik P; Shanahan F
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):47-61. PubMed ID: 12617882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease.
    Famularo G; Mosca L; Minisola G; Trinchieri V; De Simone C
    Curr Pharm Des; 2003; 9(24):1973-80. PubMed ID: 12871183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics in the treatment of inflammatory bowel disease.
    Rioux KP; Fedorak RN
    J Clin Gastroenterol; 2006 Mar; 40(3):260-3. PubMed ID: 16633133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics for inflammatory bowel disease: a critical appraisal.
    Sans M
    Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics and prebiotics in inflammatory bowel disease: microflora 'on the scope'.
    Damaskos D; Kolios G
    Br J Clin Pharmacol; 2008 Apr; 65(4):453-67. PubMed ID: 18279467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.